---
document_datetime: 2023-09-21 21:08:48
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/steps-after-cutoff/starlix-epar-steps-taken-after-authorisation-when-cutoff-date-has-been-used_en.pdf
document_name: starlix-epar-steps-taken-after-authorisation-when-cutoff-date-has-been-used_en.pdf
version: success
processing_time: 1.187594
conversion_datetime: 2025-12-22 11:41:40.980492
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Procedural steps taken after granting the Marketing Authorisation

For procedures finalised after 1 February 2004 please refer to module 8B.

Subsequent post Marketing Authorisation applications agreed upon are summarised in the table below:

<!-- image -->

| Scope                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | Application number   | Type of modification 1   | Notification/ Opinion issued on 2   | Commission Decision Issued/amended on authorised   |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------|--------------------------|-------------------------------------|----------------------------------------------------|
| Replacement of an excipient with a comparable excipient                                                                                                                                                                                                                                                                                                                                                                                                                | I/0001               | I                        | 08.06.01                            | -                                                  |
| Change to addresses of some local representatives                                                                                                                                                                                                                                                                                                                                                                                                                      | N/0002               | N                        | 19.12.01                            | -                                                  |
| Addition of a manufacturing site for Starlix film-coated tablets and change in the batch release site                                                                                                                                                                                                                                                                                                                                                                  | I/0003               | I                        | 12.06.02                            | 11.07.02                                           |
| Change in manufacturing batch size of finished product                                                                                                                                                                                                                                                                                                                                                                                                                 | I/0004               | I                        | 12.06.02                            | -                                                  |
| Addition of an alternative packaging site                                                                                                                                                                                                                                                                                                                                                                                                                              | I/0005               | I                        | 24.05.02                            | -                                                  |
| Addition of an alternative packaging site                                                                                                                                                                                                                                                                                                                                                                                                                              | I/0006               | I                        | 24.05.02                            | -                                                  |
| Extension of product shelf-life                                                                                                                                                                                                                                                                                                                                                                                                                                        | I/0007               | I longer                 | 17.06.02                            | 30.08.02                                           |
| Change to the finished product specification                                                                                                                                                                                                                                                                                                                                                                                                                           | I/0008               | I                        | 10.10.02                            | -                                                  |
| Update of the Summary of Product Characteristics (SPC) to include new information regarding the interaction between nateglinide and sulfinpyrazone and to include information on the co-administration of nateglinide and gemfibrozil. The Package Leaflet has been updated accordingly. The paragraph on hepato-biliary disorders in section 4.8 of the SPC has been updated. In addition minor changes and an update of the local representatives have been done. no | II/0009              | II                       | 25.09.03                            | 14.01.04                                           |

I refers to a minor variation (Type I variation); II refers to a major variation (Type II variation); I/II refers to a minor variation following the procedure set out in Article 6, 7 and 8 of the Regulation; X refers to an Annex II application.

1 For variations before 1 October 2003 in accordance with Commission Regulation (EC) No. 542/95 of 10  March  1995,  as  amendedand  and  for  variations  after  1  October  2003  in  accordance  with Commission Regulation (EC) No. 1085/2003: Medicinal Product no longer authorised

T refers to a transfer of a Marketing Authorisation in accordance with Commission Regulation (EC) No 2141/96 of 7 November 1996.

N refers to a notification in accordance with Article 61(3) of Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001.

2 For Notifications and Type I variations, the date of entry into force of the change is the EMEA Notification date. The Commission Decision will be amended accordingly.